ARTICE® Real Data Collection & Observational Trial, Phase 4 Study (ARTistry)

Artcline

Status: Enrolling

Conditions: Immunoparalysis in Septic Shock; Septic Shock; Sepsis

Study type: Observational

Funder types: Industry

Identifiers

NCT07388628

ARTistry

Details and patient eligibility

About

The objectives of this registry study are to:

1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects.
2. Further evaluate ARTICE® treatment efficacy.
3. Identify potential sub-groups, assess their risk-benefit- and safety profile.
4. Changes in SOFA score D0 to SOFA Score D7.

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects ≥ 18 years who are planned to receive ARTICE® treatment during their ICU stay

Exclusion criteria

-